Charleston, SC -- (SBWIRE) -- 12/11/2013 -- otcstockcenter.com, provide information specifically for trades in the micro-cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Let’s have a look on Few Hot Stocks: Novavax, Inc. (NASDAQ:NVAX), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Opko Health Inc. (NYSE:OPK), Cameron International Corporation (NYSE:CAM)
Novavax, Inc. (NASDAQ:NVAX) was trading lower by -0.07 points or -1.67% to $4.12.So far, around 1.46 million shares have changed hands in this session. After opening at $4.33, the stock hit as high as $4.34. However, it traded between $1.68 and$4.34 over the last twelve months. Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs).
Has NVAX Found The Bottom and Ready To Move Up? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) was at $3.39, showing a -20.99% decrease. Around 7.75 million shares have been traded, versus an-average trading volume of 1.72M shares. The company is now valued at around $4.93.29 million. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders.
Has AVNR Found The Bottom And Ready To Gain Momentum? Find Out Here
Opko Health Inc. (NYSE:OPK) moved -15.22 per cent lower at $9.75 and is trading between $9.74 and $11.09 after opening the day at $11.05. Its performance over the last five days remained -7.4%, which stands at -5.15% for a month. Going back further than one month, 1-year performance after recent close was 102.91%. OPKO Health, Inc. (OPKO) is a multi-national pharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, point-of-care tests, and pharmaceuticals and vaccines.
Why Should Investors Buy OPK After the Recent Fall? Just Go Here and Find Out
Cameron International Corporation (NYSE:CAM) shares rose today, gaining 2.68 per cent to $56.35. The stock is down around -0.35% in 2013 and 1.81% for the last 12 months. Around 4.29 million shares changed hands so far in this session compared to an-average trading volume of 3.50M shares. Cameron International Corporation provides flow equipment products, systems and services to worldwide oil, gas and process industries.
Why Should Investors Buy CAM After The Recent Gain? Just Go Here and Find Out
About OTC Stock Center:
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)